Displaying drugs 6726 - 6750 of 7313 in total
Setrobuvir
Setrobuvir has been used in trials studying the treatment of Hepatitis C, Chronic.
Investigational
ASP-3026
ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, and Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS.
Investigational
CCX-354
CCX354-C has been used in trials studying the treatment of Rheumatoid Arthritis.
Investigational
MLN8054
MLN8054 has been used in trials studying the treatment of Colon Neoplasm, Breast Neoplasm, Bladder Neoplasm, Pancreatic Neoplasm, and Advanced Malignancies.
Investigational
Olmutinib
Olmutinib is an orally active epidermal growth factor receptor inhibitor used in the treatment of T790M mutation positive non-small cell lung cancer. It is available under the brand name Olita made by Hanmi Pharmaceuticals . Olmutinib was developed by Hanmi Pharmaceuticals and Boehringer Ingelheim. Olmutinib recieved breakthrough therapy designation in...
Investigational
Parsaclisib
Parsaclisib is under investigation in clinical trial NCT03126019 (An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)).
Investigational
(C8-R)-hydantocidin 5'-phosphate
Experimental
D-naphthyl-1-acetamido boronic acid alanine
Experimental
L-naphthyl-1-acetamido boronic acid alanine
Experimental
8-Bromo-Adenosine-5'-Monophosphate
Experimental
Chromophore (Met-Tyr-Gly)
Experimental
7-methyl-5'-guanylic acid
Experimental
SP2456
Experimental
Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline
Experimental
Paclitaxel docosahexaenoic acid
A combination of docosahexaenoic Acid (a natural fatty acid) and paclitaxel (an anticancer drug) being studied in the treatment of cancer. It is a type of mitotic inhibitor.
Investigational
Tonabersat
Investigational
Ilepatril
Investigational
Displaying drugs 6726 - 6750 of 7313 in total